Sun, L., Yang, M., Zhang, X., Li, H., Wu, L., Zhang, Y., & Cai, S. (2020). Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case report. Medicine (Baltimore).
Chicago Style CitationSun, Li, Meng Yang, Xuan Zhang, Hua Li, Lingying Wu, Yuzi Zhang, i Shangli Cai. "Anlotinib Combined With Etoposide for Platinum-resistant Recurrent Ovarian Cancer: A Case Report." Medicine (Baltimore) 2020.
Cita MLASun, Li, et al. "Anlotinib Combined With Etoposide for Platinum-resistant Recurrent Ovarian Cancer: A Case Report." Medicine (Baltimore) 2020.
Atenció: Aquestes cites poden no estar 100% correctes.